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Abstract
Injection drug users (IDUs) in San Juan, Puerto Rico are characterized by high rates of daily
injecting, injection of shared drugs, re-use of injection syringes, and use of shooting galleries. They
lack adequate access to new injection syringes and drug preparation equipment, and experience
elevated rates of HIV and HCV infection. Between April and August, 2006, researchers and active
IDUs collaborated in the development of an experimental HIV/HCV intervention aimed at
identifying drug preparation items and practices that will enable IDUs to make drug solutions
without potentially contaminated injection syringes contacting materials used to prepare drugs.
The collaboration involved discussing and testing a variety of drug preparation items and practices
in office and community settings. The process was repeated until concerns that had been raised
were resolved, and a tentative set of intervention items and practices to be evaluated in a
community field trial was identified. Throughout, a strong emphasis was placed on the capacity of
an item or practice to address common problems confronted by IDUs (blunted needles, clogged
syringes, injected particles) in addition to the core aim of reducing contamination of preparation
materials by blood in injection syringes.
This report describes the final selection of items and practices: 1) A small water bottle that permits
IDUs to add approximately .05 cc water drops directly to drug powder in cookers; 2) A
preparation syringe (a type of ancillary equipment not used for injecting) that permits IDUs to pull
up a measurable amount of water to add to drug powder, an alternative to producing water drops;
3) A filtering device, the Sterifilt filter, attached to a preparation syringe, which eliminates the need
for cotton or cigarette filters; 4) Use of a preparation syringe to distribute drug solution by
backloading to injection syringe(s); 5) A small water bottle enabling IDUs to clean injection syringes
by backload rinsing. The overarching aim of this experimental HIV/HCV intervention was to
promote the safe re-use of drug preparation and injection items, and to impact the large number
of IDUs in San Juan who maintain personal injection syringes, but currently use communal ancillary
equipment in shooting galleries and inject drug solutions prepared with other IDUs' injection
syringes.
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Background
HIV and HCV infection among injection drug users
(IDUs) in Puerto Rico constitutes a public health emer-
gency even after two decades of epidemiological and
anthropological research [1]. Recent studies of street-
recruited IDUs in San Juan document HIV seroprevalence
of 21% [2] and HCV seroprevalence of 89% [3]. Behind
these disturbing statistics are consistently high levels of
risky injection behaviors, including number of daily injec-
tions [4], utilization of shooting galleries [5], joint drug
purchase and injection of shared drugs [6], and re-use of
injection equipment [7]. At present, IDUs are unable to
access adequate numbers of new syringes or ancillary
injection equipment. The estimated 15,935 IDUs residing
in San Juan [8] inject a mean of 184 times each month [9],
meaning that 2,932,040 new syringes need to be circu-
lated monthly if injection syringes are not to be re-used.
The one source of free syringes and ancillary equipment is
the needle exchange program which lacks funding to rou-
tinely provide HIV/HCV prevention kits [10] and cur-
rently distributes less than 1% of the syringes needed
monthly (J. Negron, unpublished data). Not surprisingly,
IDUs attempt to extend the life of each syringe, resulting
in a mean reuse rate of six times per syringe [11].
In response to this public health crisis, researchers and
IDUs from San Juan are collaborating in an experimental
HIV/HCV prevention intervention aimed at identifying
drug preparation items and practices that will enable
IDUs to make a drug solution using ancillary equipment
not exposed to blood, and to transfer the solution to the
barrel of an injection syringe after its plunger is removed
(i.e., by backloading). This report describes the initial
phase in the development of the intervention in which
potential items and practices were identified and tested
through an iterative process until concerns raised in office
and community settings were resolved. Throughout, the
capacity of an item or practice to address common prob-
lems IDUs confront (e.g., blunted needles, injected parti-
cles) received special attention, in addition to the central
aim of reducing contamination of preparation materials
by blood in injection syringes.
Methods
Selection criteria for participating IDUs included: current
drug injecting, age 18 or older, Puerto Rican self-identifi-
cation, residential stability, and expressed interest in drug
injecting innovation. An outreach worker contacted 18
potential participants; 10 (7 males, 3 females) were
selected after a screening interview with the project eth-
nographer. Five IDUs were recruited from one San Juan
community and five from a second community. Partici-
pants received information about study objectives, activi-
ties, confidentiality protections and compensation.
Participants received $20.00 for each of three office-based
sessions; 9 of the 10 participants attended all three ses-
sions. The amount of compensation was comparable to
payments for focus group participation in recent HIV/
HCV studies. Participants were not compensated mone-
tarily for testing potential intervention items in commu-
nity settings. The UCC Institutional Review Board
approved all study procedures.
The office-based sessions were held in community cent-
ers. Three rounds of sessions were conducted between
April and August, 2006. For each round, a session was
held in one community, and on the following day a ses-
sion was held in the other community. Thus the three
rounds produced a total of six sessions. At the beginning
of each session, participants were offered refreshments;
sessions lasted about 1.5 hours.
The content of office-based sessions changed as the inter-
vention evolved, however all sessions followed a similar
structure: introductory comments about the study's objec-
tives; demonstrations and discussions (e.g., current drug
preparation practices, potential intervention items and
practices); concluding remarks about arrangements for
supplying participants with samples of items under con-
sideration.
Audio-visual recordings were made of each session with
the participants' prior consent. In Round I, a single sta-
tionary camera recorded the facilitator and session partic-
ipants. In Rounds II and III, a second hand-held camera
was added, which provided close-ups of participants'
hands as they demonstrated or practiced using different
items. Within two days of a round of sessions, the research
team examined audio-visual recordings, taking detailed
notes and transcribing participants' comments. The
research team then discussed the issues raised during the
sessions and identified steps to be taken for up-coming
sessions.
Findings
Researchers and IDUs discussed and tested several drug
preparation items and practices before making a final
selection, described below, to be evaluated in a commu-
nity field trial.
Forming the drug solution (putting water into a cooker 
containing drug powder)
Two potential intervention items and practices were iden-
tified. (1) The flip-top bottle (Figure 1a) is easily refilled
and permits IDUs to add approximately .05 cc water drops
to powder in cookers. This particular unit of water facili-
tates quick calculation of the total amount of water
needed (e.g., 8 drops for .40 cc water). The bottle is a 1.25
oz natural color, low-density polyethylene (LDPE) oval
bottle with 18 mm flip top cap and 4 mm uncontrolledHarm Reduction Journal 2008, 5:14 http://www.harmreductionjournal.com/content/5/1/14
Page 3 of 5
(page number not for citation purposes)
dropper orifice. The unit cost of this item is $0.23. (2) A
preparation syringe (i.e., a syringe that is not used for
injecting and is considered a type of ancillary equipment)
referred to as La Criolla (Figure 1b) permits IDUs to pull
up a measurable amount of water to add to drug powder,
an alternative to producing water drops using the flip-top
bottle. This preparation syringe is a modified 1 cc 28
gauge insulin syringe commonly used by IDUs in San
Juan. The metal needle is replaced with a 3/8 inch seg-
ment of Teflon tubing affixed to the syringe with epoxy,
and a thin layer of clear lacquer is applied to the numbers
on the barrel. La Criolla costs $0.27 each to produce and
has the advantages of number markings familiar to IDUs
and number markings that do not rub off easily.
Filtering the drug solution
One filtering device, the Sterifilt filter (Figure 1c), which
fits on the preparation syringe described above (Figure
1d), was selected after tests conducted by researchers and
IDUs. The Sterifilt filter is a commercially available harm
reduction device consisting of a polypropylene body and
paper membrane; it is designed to fit onto a syringe and
be used a single time. This filter costs $0.21 per unit and
blocks "90% of particles measuring less than five
microns," and retains three times less drug than filters
commonly used by IDUs, including cotton and cigarette
filters [12]. Of all items considered during the study, IDUs
expressed greatest interest in the Sterifilt filter primarily
because it blocks small particles that clog syringes and, if
injected, cause a painful reaction known as "cotton fever."
Also, filtering solutions with a Sterifilt filter attached to a
preparation syringe result in less use, and thus less blunt-
ing, of injection syringe needles.
Study researchers conducted ten office-based trials to
determine the number of possible filter re-uses. Each trial,
repeated 23–29 times, involved drawing up approxi-
mately .5 cc water with a Sterifilt-fitted syringe, removing
the filter, holding the membrane against a light bulb, and
visually inspecting for ruptures and separations of the
paper membrane from the polypropylene body. Survival
probability was calculated after each trial; the filter had a
90% probability of surviving six uses.
Distributing filtered drug solution to injection syringe(s)
Researchers and IDUs identified a potential intervention
practice of using the preparation syringe, La Criolla, to dis-
tribute filtered drug solution by backloading to injection
syringes (Figure 1e). Advantages include: imperceptible
drug retention (i.e., low dead space), widespread familiar-
ity with backloading, familiar number markings on prep-
aration syringe that facilitate determination of solution
volume and fair division of portions, and a Teflon needle
structure that permits safe transfer of drug solution to
injection syringe(s).
Cleaning injection syringe
IDUs in San Juan normally rinse a re-used injection
syringe by drawing up and expelling a small amount of
water (e.g., .40 cc) through the syringe's metal needle. An
alternative to this practice, referred to as backload rinsing,
was identified. It involves removing the plunger from the
injection syringe; directing a strong, narrow stream of
water from the flip-top bottle (Figure 1a) into the syringe
barrel, filling its entire length; replacing the plunger;
expelling the water out the metal needle. Advantages
include: a) the upper portion of the barrel is rinsed (this
part is often exposed to drug solution but inadequately
rinsed by the traditional cleaning method); b) the need
for small, communal water receptacles (tapitas) for rinsing
Final selection of intervention items Figure 1
Final selection of intervention items. A small flip-top 
water bottle (1a) permits IDUs to add approximately .05 cc 
water drops directly to drug powder in cookers and to clean 
injection syringes by backload rinsing. A preparation syringe 
(1b), a type of ancillary equipment not used for injecting, per-
mits IDUs to pull up a measurable amount of water to add to 
drug powder, an alternative to producing water drops with 
the small water bottle. The Sterifilt filter (1c) attached to a 
preparation syringe (1d) eliminates the need for cotton or 
cigarette filters. Drug solution, having been filtered and 
drawn up into the preparation syringe, is transferred to an 
injection syringe (1e). The intervention kit (1f) includes a flip-
top water bottle, cooker, preparation syringe (La Criolla), 
Sterifilt filters, and bottle of alcohol sanitizer.Harm Reduction Journal 2008, 5:14 http://www.harmreductionjournal.com/content/5/1/14
Page 4 of 5
(page number not for citation purposes)
injection syringes is eliminated; c) IDUs gain personal
control over the water used to rinse injection syringes.
Discussion
IDUs in San Juan are unable to access adequate numbers
of new syringes and drug preparation equipment, a situa-
tion unlikely to change in the foreseeable future. This
report describes initial steps in the development of an
experimental intervention that enables IDUs to prepare
drug solutions without HIV/HCV-contaminated injection
syringes contacting drug preparation materials. The over-
arching aim is to promote the safe re-use of drug prepara-
tion and injection equipment, and to impact the large
number of IDUs in San Juan who maintain personal injec-
tion syringes but use communal ancillary equipment in
shooting galleries and inject drug solutions prepared with
other IDUs' injection syringes.
The high level of participant attendance at the three ses-
sions has been critical to the realization of study goals,
and was achieved by: a) offering substantial monetary
compensation; b) holding small group sessions to facili-
tate detailed demonstrations and discussions of injection
practices; c) selecting participants on the basis of neigh-
borhood residence to ensure social ease at the sessions; d)
conducting sessions at community centers close to where
participants live and engage in daily activities. An addi-
tional distinctive factor in sustaining participant interest
was the overt recognition by researchers of the expert
knowledge and skills possessed by participating IDUs.
Both male and female IDUs contributed to this study but
gender did not appear to be relevant in the discussions,
testing, or selection of items for the intervention kit (Fig-
ure 1f). All of the participants were veteran IDUs with gen-
erally comparable drug-related knowledge and skills, and
access to monetary resources. They engaged in similar
drug injection practices, each maintaining a personal
syringe but engaging in indirect sharing (e.g., using com-
munal cookers and water receptacles, distributing the con-
tents of their syringe to others, injecting drug solutions
prepared by other IDUs). Even though gender was not a
significant factor in this initial study, it is possible that
important gender differences may exist in the ability of
IDUs to carry or store intervention items because kits are
easily added to women's purses, and women are less sub-
ject than males to police searches in San Juan. Gender dif-
ferences in adoption rates may also appear if the
intervention is introduced to a larger sample of IDUs in
which there are differences between males and females in
injection practices (e.g., women in certain circumstance
may be less likely to control the drug preparation proc-
ess). These issues will be explored when the intervention
is evaluated in community trials. It is hoped that this
intervention proves to be beneficial for IDUs in Puerto
Rico and perhaps for other IDU populations that experi-
ence inadequate access to programs, including syringe
exchange programs, shown to be effective in addressing
HIV and viral hepatitis.
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